Frontotemporal dementia (FTD): management
Written and reviewed by Dr Ibrahim Imam, Consultant Neurologist. Last reviewed .
Frontotemporal dementia (FTD): management. Disinhibition, Stereotypy, Depression, Inappropriate sexual behaviour. Fully referenced neurology checklist.
Selective serotonin reuptake inhibitors (SSRIs): indications
- Disinhibition
- Stereotypy
- Depression
- Inappropriate sexual behaviour
Treatment of emotional fluctuations
Locked: subscribe to see this section.
Potential treatments
Locked: subscribe to see this section.
Other management approaches
Locked: subscribe to see this section.
Investigational treatments
Locked: subscribe to see this section.
References
- Mendez MF, Lauterbach EC, Sampson SM, ANPA Committee on Research. An evidence-based review of the psychopathology of frontotemporal dementia: a report of the ANPA Committee on Research. J Neuropsychiatry Clin Neurosci 2008; 20:130-149.
- Boxer AL, Boeve BF. Frontotemporal dementia treatment: current symptomatic therapies and implications of recent genetic, biochemical, and neuroimaging studies. Alzheimer Dis Assoc Disord 2007; 21:S79-S87.
- Tsai RM, Boxer AL. Treatment of frontotemporal dementia. Curr Treat Options Neurol 2014; 16:319.
- Coleman KKL, Berry S, Cummings J, et al. Intranasal oxytocin for apathy in people with frontotemporal dementia (FOXY): a multicentre, randomised, double-blind, placebo-controlled, adaptive, crossover, phase 2a/2b superiority trial. Lancet Neurol 2025 (Online ahead of print).
